
USA - NASDAQ:STML -
ChartMill assigns a Buy % Consensus number of 77% to STML. The Buy consensus is the weighted average rating of the current analysts ratings.
The consensus rating for Stemline Therapeutic (STML) is 77.2 / 100 . This indicates that analysts generally have a positive outlook on the stock.